phase 2/phase 3 clinical trial
Term · Oncology and biomedicine · MLC-T-ONC-006593
A study that tests how well a new treatment works for a certain type of cancer or other disease and compares the new treatment with a standard treatment. Phase 2/phase 3 clinical trials may also provide more information about the safety and side effects of the new treatment. Combining phases 2 and 3 may allow research questions to be answered more quickly or with fewer patients. Also called phase II/III clinical trial.
| Identifier | MLC-T-ONC-006593 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | phase II/III clinical trial |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-006593",
"term": "phase 2/phase 3 clinical trial",
"field": "Oncology and biomedicine",
"definition": "A study that tests how well a new treatment works for a certain type of cancer or other disease and compares the new treatment with a standard treatment. Phase 2/phase 3 clinical trials may also provide more information about the safety and side effects of the new treatment. Combining phases 2 and 3 may allow research questions to be answered more quickly or with fewer patients. Also called phase II/III clinical trial.",
"synonyms": [
"phase II/III clinical trial"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/phase-2-phase-3-clinical-trial/"
}
Record 13,088 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.